Giant Cell Tumor — Trials

Giant Cell Tumor — Trials · CancerIndex

Clinical trials

Registered studies

52 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03069469	Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor	active not recruiting	Phase 1 / Phase 2	120	Deciphera Pharmaceuticals, LLCINDUSTRY	9	Jun 25, 2026	clinicaltrials
NCT03449108	LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas	active not recruiting	Phase 2	30	M.D. Anderson Cancer CenterOTHER	1	May 22, 2026	clinicaltrials

Data updated 22 days agoSource updated Jun 25, 2026source: clinicaltrials